Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

486 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
9-month clinical, angiographic, and intravascular ultrasound results of a prospective evaluation of the Axxess self-expanding biolimus A9-eluting stent in coronary bifurcation lesions: the DIVERGE (Drug-Eluting Stent Intervention for Treating Side Branches Effectively) study.
Verheye S, Agostoni P, Dubois CL, Dens J, Ormiston J, Worthley S, Trauthen B, Hasegawa T, Koo BK, Fitzgerald PJ, Mehran R, Lansky AJ. Verheye S, et al. Among authors: fitzgerald pj. J Am Coll Cardiol. 2009 Mar 24;53(12):1031-9. doi: 10.1016/j.jacc.2008.12.012. J Am Coll Cardiol. 2009. PMID: 19298915 Free article. Clinical Trial.
Effect of everolimus-eluting stents in different vessel sizes (from the pooled FUTURE I and II trials).
Tsuchiya Y, Lansky AJ, Costa RA, Mehran R, Pietras C, Shimada Y, Sonoda S, Cristea E, Negoita M, Dangas GD, Moses JW, Leon MB, Fitzgerald PJ, Müller R, Störger H, Hauptmann KE, Grube E. Tsuchiya Y, et al. Among authors: fitzgerald pj. Am J Cardiol. 2006 Aug 15;98(4):464-9. doi: 10.1016/j.amjcard.2006.02.054. Epub 2006 Jun 19. Am J Cardiol. 2006. PMID: 16893698 Clinical Trial.
Percutaneous coronary revascularization using a trilayer metal phosphorylcholine-coated zotarolimus-eluting stent.
Abizaid A, Lansky AJ, Fitzgerald PJ, Tanajura LF, Feres F, Staico R, Mattos L, Abizaid A, Chaves A, Centemero M, Sousa AG, Sousa JE, Zaugg MJ, Schwartz LB. Abizaid A, et al. Among authors: fitzgerald pj. Am J Cardiol. 2007 May 15;99(10):1403-8. doi: 10.1016/j.amjcard.2006.12.064. Epub 2007 Apr 4. Am J Cardiol. 2007. PMID: 17493469 Clinical Trial.
Analysis of bifurcation lesions treated with novel drug-eluting dedicated bifurcation stent system: intravascular ultrasound results of the AXXESS PLUS trial.
Miyazawa A, Ako J, Hassan A, Hasegawa T, Abizaid A, Verheye S, McClean D, Neumann FJ, Grube E, Honda Y, Fitzgerald PJ. Miyazawa A, et al. Among authors: fitzgerald pj. Catheter Cardiovasc Interv. 2007 Dec 1;70(7):952-7. doi: 10.1002/ccd.21269. Catheter Cardiovasc Interv. 2007. PMID: 18044777 Clinical Trial.
A novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single and multivessel coronary disease: primary results of the COSTAR (Cobalt Chromium Stent With Antiproliferative for Restenosis) II study.
Krucoff MW, Kereiakes DJ, Petersen JL, Mehran R, Hasselblad V, Lansky AJ, Fitzgerald PJ, Garg J, Turco MA, Simonton CA 3rd, Verheye S, Dubois CL, Gammon R, Batchelor WB, O'Shaughnessy CD, Hermiller JB Jr, Schofer J, Buchbinder M, Wijns W; COSTAR II Investigators Group. Krucoff MW, et al. Among authors: fitzgerald pj. J Am Coll Cardiol. 2008 Apr 22;51(16):1543-52. doi: 10.1016/j.jacc.2008.01.020. J Am Coll Cardiol. 2008. PMID: 18420096 Free article. Clinical Trial.
486 results